Filing Details

Accession Number:
0001209191-10-028764
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-18 13:00:00
Reporting Period:
2010-05-13
Filing Date:
2010-05-18
Accepted Time:
2010-05-18 19:28:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238250 A Michael Martino 1522 217Th Pl Se, Suite 100
Bothell WA 98021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-13 2,726 $6.66 13,726 No 4 M Direct
Common Stock Disposition 2010-05-13 2,726 $19.20 11,000 No 4 S Direct
Common Stock Acquisiton 2010-05-17 10,368 $6.66 21,368 No 4 M Direct
Common Stock Disposition 2010-05-17 10,368 $18.53 11,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2010-05-13 2,726 $0.00 2,726 $6.66
Common Stock option (right to buy) Disposition 2010-05-17 10,368 $0.00 10,368 $6.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,885 2008-03-18 2018-03-18 No 4 M Direct
10,517 2008-03-18 2018-03-18 No 4 M Direct
Footnotes
  1. This is the weighted average price. The prices ranged from $18.50 to $19.00. The reporting person undertakes to provide on request a detailed breakout of the pricing.